Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Patients with active suicidal ideation, recent psychiatric hospitalization, or unstable bipolar disorder should not start a GLP-1 agent through any telehealth platform without documented coordination with their treating psychiatrist
58, Klaipda, Tel
Qsymia requires careful monitoring for interactions with MAO inhibitors, other stimulants, carbonic anhydrase inhibitors, and medications affecting kidney stone formation due to its topiramate component
Severe gastrointestinal disease , particularly severe gastroparesis, may preclude the use of these medications
US$ 23.82
US$ 21.36
US$ 22.29
